1. Myeloid-derived suppressor cells ameliorate liver mitochondrial damage to protect against autoimmune hepatitis by releasing small extracellular vesicles
   Mengyi Shen et al, 2023, International Immunopharmacology CrossRef
2. Progress in research on the role played by myeloid‐derived suppressor cells in liver diseases
   Qianqian Sun et al, 2023, Scandinavian Journal of Immunology CrossRef
3. Surgical Primary Tumor Resection Reduces Accumulation of CD11b+ Myeloid Cells in the Lungs Augmenting the Efficacy of an Intranasal Cancer Vaccination against Secondary Lung Metastasis
   Michael Donkor et al, 2023, Pharmaceuticals CrossRef
4. Tet2 deficiency drives liver microbiome dysbiosis triggering Tc1 cell autoimmune hepatitis
   Surya P. Pandey et al, 2022, Cell Host & Microbe CrossRef
5. The Sweet Surrender: How Myeloid Cell Metabolic Plasticity Shapes the Tumor Microenvironment
   Je Lin Sieow et al, 2018, Frontiers in Cell and Developmental Biology CrossRef
6. Granulocyte-Macrophage Colony-Stimulating Factor Modulates Myeloid-Derived Suppressor Cells and Treg Activity in Decompensated Cirrhotic Patients With Sepsis
   Rashi Sehgal et al, 2022, Frontiers in Immunology CrossRef
7. Myeloid-Derived Suppressive Cells Deficient in Liver X Receptor α Protected From Autoimmune Hepatitis
   Bo Li et al, 2021, Frontiers in Immunology CrossRef
8. Ocular Immune Privilege and Transplantation
   Andrew W. Taylor, 2016, Frontiers in Immunology CrossRef
9. Autoimmune Hepatitis
   Zhou Yuming et al, 2024, Clinics in Liver Disease CrossRef
10. The relationship between myeloid-derived supressor cells and clinico-laboratory parameters in patients with liver cyrrosis
    O. Yu Leplina et al, 2021, Genes & Cells CrossRef
11. MDA5-dependent responses contribute to autoimmune diabetes progression and hindrance
    Samuel I. Blum et al, 2023, JCI Insight CrossRef
12. Role of myeloid-derived suppressor cells in chronic brucellosis
    Shuiping Hou et al, 2024, Frontiers in Cellular and Infection Microbiology CrossRef